Several studies have confirmed the relationship between tumor-derived IL-6 and MDSCs in a wide variety of tumor types such as esophageal cancer, prostate cancer, and hepatocellular carcinoma (11, 41, 42). This evidence concerns the gene IL6 and prostate carcinoma.